Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Insulin-like growth factor binding protein 3 chemosensitizes pancreatic ductal adenocarcinoma through its death receptor

Tue Sep 26 14:54:17 2023

(2020) Insulin-like growth factor binding protein 3 chemosensitizes pancreatic ductal adenocarcinoma through its death receptor. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... et al.. ISSN 1424-3911 (Electronic) 1424-3903 (Linking)

Full text not available from this repository.

Official URL: https://www.ncbi.nlm.nih.gov/pubmed/32830034

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. Gemcitabine and doxorubicin are commonly used as the chemotherapy agents, but most of PDAC tumors eventually acquired resistance to chemotherapy. Accumulating evidence indicates that Insulin-like growth factor binding protein 3 (IGFBP-3) plays a key role against tumor growth but its expression has commonly suppressed. The present study was designed to evaluate IGFBP-3 effects in chemotherapy sensitization of PDAC cells. Here, we report that the re-sensitization of chemoresistant PDAC cells was occurred by IGFBP-3 through recruitment of its death receptor (IGFBP-3R). Using gemcitabine, doxorubicin-resistant PDAC cell lines, we found that IGFBP-3 sensitized chemoresistant cells by activating apoptosis (as evaluated by Bax up-regulation, Bcl-2 down-regulation as well as Caspase-3 and Caspase 8 activation). IGFBP-3R was also found to have higher expression level in resistant AsPc-1 and MIA PaCa-2 cells in comparison to parental cells. IGFBP-3R was also highly expressed in PDAC tumor which exposed to chemotherapy in comparison to un-treated PDAC tumors. In addition, we confirmed our finding by using specific siRNA to knocking down of IGFBP-3R which prevents IGFBP-3 Chemosensitization. Taken together, the present study for the first time indicates the clinical relevance for combining IGFBP-3 with chemotherapy to reduce chemoresistance in PDAC.

Item Type: Article
Creators:
CreatorsEmail
Mofid, M. R.UNSPECIFIED
Gheysarzadeh, A.UNSPECIFIED
Bakhtiyari, S.UNSPECIFIED
Keywords: Chemosensitization Igfbp-3 Igfbp-3r Pdac
Divisions:
Journal or Publication Title: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... et al.
Journal Index: Pubmed
Identification Number: https://doi.org/10.1016/j.pan.2020.07.406
ISSN: 1424-3911 (Electronic) 1424-3903 (Linking)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/3112

Actions (login required)

View Item View Item